Psyence Biomedical Ltd (PBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 12-2023 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,171 | 763 | 763 | N/A | N/A |
| Receivables | 137 | 42 | 42 | N/A | N/A |
| Other current assets | 0 | 0 | 322 | 0 | 0 |
| TOTAL | $6,560 | $1,127 | $1,127 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 11 | 6 | 6 | N/A | N/A |
| Investments And Advances | 745 | 0 | 0 | 0 | 0 |
| TOTAL | $756 | $6 | $6 | $N/A | $N/A |
| Total Assets | $7,316 | $1,132 | $1,132 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 394 | 3,546 | 0 | 0 | 0 |
| Other current liabilities | 200 | 902 | N/A | N/A | N/A |
| TOTAL | $594 | $12,105 | $12,105 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $594 | $12,105 | $12,105 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 61,752 | 46,125 | N/A | N/A | N/A |
| Retained earnings | -56,447 | -57,459 | -57,459 | N/A | N/A |
| Other shareholders' equity | 1,417 | 361 | 46,487 | 0 | 0 |
| TOTAL | $6,722 | $-10,973 | $-10,973 | $N/A | $N/A |
| Total Liabilities And Equity | $7,316 | $1,132 | $1,132 | $0 | $0 |